ScriptPro President Presents to the FDA
ScriptPro President and CEO Michael E. Coughlin has presented
a pharmacy industry perspective on the importance of barcodes
on drug products and related medical supplies. This presentation
to the FDA is one way in which ScriptPro has been proactive in
its efforts to advance medication dispensing safety and compliance
through the use of pharmacy automation.
Coughlin explained that medication errors related to drug dispensing
and use can be minimized through systems that operate in conjunction
with improved barcodes on drug products and related medical supplies.
His report to the FDA outlines
problems with the current drug numbering and bar coding system
in the U.S. and provides examples of how these problems cause
errors.
For more information on Coughlin’s presentation, please see the
official press
release or call Leslie Bayer at 913.403.5425.
From: Michael E. Coughlin, President and CEO, ScriptPro
Date: July 26, 2002
Re: Food and Drug Administration (FDA), HHS, Public Meeting
|
Download This Section
as an Acrobat File |
Download
the Complete Report as an Acrobat File. |
|
|
|
Barcode Label Requirements for Human Drug
Products
July 26,
2002, from 9 a.m. to 5 p.m.
Natcher Auditorium, Building 45
National Institutes of Health, Bethesda,
MD
RECOMMENDATIONS
FOR THE DEVELOPMENT OF A REGULATION ON BARCODE LABELING FOR
HUMAN DRUG PRODUCTS, INCLUDING BIOLOGIC PRODUCTS
I. Background
II. Dispensing Errors - Cause and Prevention
III. Barcode Driven Systems
SP 200
